institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

New Biomarker Enables Early and Accurate Parkinson's Diagnosis

Summary
Researchers validate cerebrospinal fluid test using iRS technology with over 90% accuracy, paving the way for early intervention and therapeutic advancements.

11 Articles

All
Left
Center
4
Right

Researchers at the PRODI Protein Diagnosis Center at the University of Ruhr in Bochum (Germany) and the biotechnological company betaSENSE have discovered a biomarker in cerebrospinal fluid that facilitates a reliable diagnosis at an early stage of Parkinson’s disease and can shed light on its progression and the effect of a therapy.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Technology Networks broke the news in on Friday, April 25, 2025.
Sources are mostly out of (0)